MedTrace Logo

The Effectiveness of Different Methods for Healing a Palatal Donor Site

NCT03567148 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-06-25

No results posted yet for this study

Summary

Postoperative complications associated with free gingival graft (FGG) procedures are prolonged bleeding from the donor site, postoperative pain and delayed wound healing which increases the patients' morbidity. Hence, the aim of this study is to assess the effectiveness of different treatment modalities on palatal wound healing and patient's morbidity after FGG. Ninety patients requiring FGG were randomly will be assigned into six groups: group 1: Platelet rich fibrin (PRF) membrane, group 2: Essix retainer, group 3: topical ozone therapy, group 4: low-level laser therapy (LLLT), group 5: collagen fleece and group 6: untreated control group. Epithelization will be evaluated by means of bubble formation; sensitivity, edema, pain, changes in eating habits and burning sensation will be assessed by using visual analog scale (VAS) and also the presence of discomfort and bleeding will be evaluated in the postoperative first week and at 14 days, 1 and 3 months postoperatively.

Conditions

  • Wound Heal
  • Graft Pain
  • Palate; Wound

Interventions

PROCEDURE

PRF

Applying to the palatal wounds

PROCEDURE

Essix retainer

Applying to the palatal wounds

PROCEDURE

Ozone therapy

Applying to the palatal wounds

PROCEDURE

LLLT

Applying to the palatal wounds

PROCEDURE

Collagen fleece

Applying to the palatal wounds

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Deniz Cetiner, Prof. Dr. · Gazi University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-12-31
Completion
2018-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03567148 on ClinicalTrials.gov